SCHEMBL24530135

SCHEMBL24530135

O=C(CCc1ccccc1)N[C@@H](CC1CC1)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIN1 Q13526 1/20 0.53
▸ LTA4H P09960 1/20 0.51
▸ ITGB3 P05106 2/20 0.51
▸ ITGA2B P08514 2/20 0.51
▸ GRN P28799 1/20 0.50
▸ SORT1 Q99523 1/20 0.50
▸ HDAC2 Q92769 1/20 0.49
▸ HDAC8 Q9BY41 1/20 0.49
▸ HDAC6 Q9UBN7 1/20 0.49
▸ EPHX2 P34913 2/20 0.47
▸ CTSG P08311 1/20 0.47
▸ CMA1 P23946 1/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ CCR1 P32246 1/20 0.47
▸ MAPT P10636 2/20 0.47
▸ GAA P10253 1/20 0.47
▸ HTT P42858 1/20 0.46
▸ HDAC1 Q13547 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29144589 1.00 PIN1 (0.53) PIN1LTA4HITGB3ITGA2BGRN
SCHEMBL7029711 0.93 LTA4H (0.60) PIN1LTA4HGRNSORT1EPHX2
SCHEMBL24530131 0.87 YAP1 (0.49) HDAC6ALDH1A1CYP2C19CCR1GAA
SCHEMBL29144580 0.83 CTSL (0.56) ITGB3ITGA2B
SCHEMBL19790129 0.81 F2 (0.51) HDAC2HDAC8HDAC6ALDH1A1CYP2C19
SCHEMBL12278423 0.81 F2 (0.51) HDAC2HDAC8HDAC6ALDH1A1CYP2C19
SCHEMBL5458748 0.80 ITGB3 (0.65) PIN1ITGB3ITGA2BHDAC2HDAC8
SCHEMBL24533898 0.80 PIN1 (0.59) PIN1ITGB3ITGA2BHDAC2HDAC8
SCHEMBL4153095 0.80 ITGB3 (0.65) PIN1ITGB3ITGA2BHDAC2HDAC8
SCHEMBL4153101 0.80 ITGB3 (0.65) PIN1ITGB3ITGA2BHDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117136178-A SARS-COV-2 Mpro inhibitor compounds 赫帕雷斯治疗有限公司 2023-11-28 — — CN disclosed
EP-4263502-A1 SARS-COV-2 MPRO INHIBITOR COMPOUNDS Heptares Therapeutics Limited (GB) 2023-10-25 — — EP disclosed
WO-2022129953-A1 SARS-COV-2 MPRO INHIBITOR COMPOUNDS HEPTARES THERAPEUTICS LIMITED (GB) 2022-06-23 — — WO disclosed
WO-2022129953-A1 SARS-COV-2 MPRO INHIBITOR COMPOUNDS HEPTARES THERAPEUTICS LIMITED (GB) 2022-06-23 — — WO disclosed
Send feedback